<DOC>
	<DOCNO>NCT02470624</DOCNO>
	<brief_summary>This multi-center registry study . The investigator include 10,000 patient confirm acute ischemic stroke China . The aim study survey current treatment situation China compare effectiveness safety different intervention regimen .</brief_summary>
	<brief_title>Chinese Acute Ischemic Stroke Treatment Outcome Registry</brief_title>
	<detailed_description>Stroke common disease China . Compared western country , many treatment regimen use clinical practice China . But treatment effect well validate . The aim study survey current treatment situation China compare effectiveness safety different intervention regimen .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Polystyrene sulfonic acid</mesh_term>
	<criteria>1. age â‰¥18 yesrs 2. confirm diagnosis ischemic stroke 3. admission within 1 week onset stroke within treatment time window patient thrombolysis treatment 4. sign inform consent 1. intracerebral hemorrhage 2. severe morbid ( estimate survival duration le 3 month ) 3. could provide followup information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>